Celltrion
068270.KS
#822
Rank
C$39.12 B
Marketcap
C$173.98
Share price
0.38%
Change (1 day)
4.55%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

P/S ratio for Celltrion (068270.KS)

P/S ratio as of December 2025 (TTM): 10.4

According to Celltrion 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.26. At the end of 2025 the company had a P/S ratio of 9.91.

P/S ratio history for Celltrion from 2008 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20259.91-3.27%
202410.2-49.56%
202320.396.43%
202210.3-26.46%
202114.1-50.29%
202028.337.83%
201920.5-26.25%
201827.8-8.01%
201730.261.79%
201618.721.36%
201515.491.3%
20148.05-53.25%
201317.227.27%
201213.5-29.26%
201119.1-12.76%
201021.994.73%
200911.31.61%
200811.1